Covance To Hold Stockholder Meeting On Feb. 18 To Vote On Acquisition By Labcorp

(RTTNews) - Covance Inc. (CVD) announced it has set a date for a special meeting of its stockholders to consider and vote on the proposed acquisition of Covance by Laboratory Corporation of America Holdings (LH) and certain other related matters. Covance noted that the special meeting will be held on February 18, 2015.

Covance stockholders of record as of the close of business on January 15, 2015 are entitled to notice of, and to vote at, the special meeting.

The proposed acquisition is subject to approval by Covance's stockholders and certain other customary closing conditions.

In November, Clinical laboratory company Laboratory Corp. of America Holdings said it entered into a definitive agreement to buy drug development firm Covance for cash and LabCorp shares totaling $105.12 per share, or for an equity value of about $6.1 billion and an enterprise value of nearly $5.6 billion.